Co-Diagnostics Inc (CODX)
1.21
+0.01
(+0.83%)
USD |
NASDAQ |
May 03, 16:00
1.23
+0.02
(+1.65%)
After-Hours: 20:00
Co-Diagnostics Enterprise Value: -20.72M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | -20.72M |
May 02, 2024 | -21.04M |
May 01, 2024 | -21.35M |
April 30, 2024 | -22.29M |
April 29, 2024 | -21.97M |
April 26, 2024 | -23.85M |
April 25, 2024 | -22.91M |
April 24, 2024 | -22.91M |
April 23, 2024 | -22.60M |
April 22, 2024 | -22.60M |
April 19, 2024 | -22.60M |
April 18, 2024 | -22.29M |
April 17, 2024 | -22.91M |
April 16, 2024 | -21.97M |
April 15, 2024 | -21.56M |
April 12, 2024 | -21.04M |
April 11, 2024 | -19.79M |
April 10, 2024 | -20.72M |
April 09, 2024 | -18.85M |
April 08, 2024 | -20.41M |
April 05, 2024 | -20.41M |
April 04, 2024 | -22.60M |
April 03, 2024 | -23.54M |
April 02, 2024 | -24.48M |
April 01, 2024 | -23.85M |
Date | Value |
---|---|
March 28, 2024 | -23.54M |
March 27, 2024 | -23.85M |
March 26, 2024 | -23.69M |
March 25, 2024 | -23.69M |
March 22, 2024 | -21.66M |
March 21, 2024 | -21.97M |
March 20, 2024 | -24.16M |
March 19, 2024 | -24.16M |
March 18, 2024 | -25.41M |
March 15, 2024 | -25.10M |
March 14, 2024 | -21.35M |
March 13, 2024 | -21.66M |
March 12, 2024 | -21.82M |
March 11, 2024 | -22.91M |
March 08, 2024 | -22.60M |
March 07, 2024 | -22.91M |
March 06, 2024 | -22.60M |
March 05, 2024 | -21.97M |
March 04, 2024 | -23.22M |
March 01, 2024 | -22.29M |
February 29, 2024 | -23.22M |
February 28, 2024 | -23.85M |
February 27, 2024 | -23.22M |
February 26, 2024 | -23.54M |
February 23, 2024 | -23.22M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-43.81M
Minimum
Jun 05 2023
843.57M
Maximum
Aug 03 2020
121.17M
Average
55.24M
Median
Jan 30 2020
Enterprise Value Benchmarks
PAVmed Inc | 76.35M |
Perspective Therapeutics Inc | 1.055B |
Electromed Inc | 148.76M |
Xtant Medical Holdings Inc | 126.76M |
Asensus Surgical Inc | 44.48M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -14.68M |
Revenue (Quarterly) | 3.555M |
Total Expenses (Quarterly) | 15.38M |
EPS Diluted (Quarterly) | -0.50 |
Gross Profit Margin (Quarterly) | 16.52% |
Profit Margin (Quarterly) | -412.8% |
Earnings Yield | -100.0% |
Normalized Earnings Yield | -107.06 |